Research and clinical trialsRResearch and clinical trialsResearch and clinical trialsEnglishPregnancyAdult (19+)BodyReproductive systemNAPrenatal Adult (19+)NA2009-09-11T04:00:00ZNicolette Caccia, MEd, MD, FRCSCRory Windrim, MB, MSc, FRCSC8.0000000000000059.00000000000001130.00000000000Flat ContentHealth A-Z<p>Learn about the importance of clinical research. The benefits and complications of phase I, phase II, and phase III trials are discussed.</p><p>A clinical trial is a research study or scientific experiment that examines the use of drugs or other interventions in treatment. It asks a specific question to try and find better ways of preventing, diagnosing, and treating certain conditions in pregnancy, childbirth, or infancy.</p><h2>Key points</h2> <ul><li>There are three phases to clinical trials with the most experimental stage being Phase I.</li> <li>Informed consent is when a person agrees to participate in a research or clinical trial or undergo a specific treatment with a full understanding of the purpose, results expected, risks and benefits and other treatments available. </li></ul>
Recherche et essais cliniquesRRecherche et essais cliniquesResearch and clinical trialsFrenchPregnancyAdult (19+)BodyReproductive systemNAPrenatal Adult (19+)NA2009-09-11T04:00:00ZNicolette Caccia, MEd, MD, FRCSCRory Windrim, MB, MSc, FRCSC8.0000000000000059.00000000000001130.00000000000Flat ContentHealth A-Z<p>Sachez pourquoi la recherche clinique est si importante. Cette section contient de l’information sur les avantages et les complications associés aux essais cliniques de phase I, de phase II et de phase II.</p><p>L’essai clinique est une étude de recherche ou une expérience scientifique par laquelle on évalue la possibilité d’utiliser des médicaments ou d’autres interventions dans le cadre d’un traitement. Elle repose sur une question spécifique que l’on examine en vue de rechercher et de trouver des moyens de prévenir, diagnostiquer et traiter des troubles affectant la grossesse, l’accouchement et la petite enfance. </p><h2>À retenir</h2> <ul><li>Les essais cliniques se présentent en trois phases dont la plus « expérimentale » est la phase I.</li> <li>Un consentement éclairé est donné lorsqu’une personne accepte de participer à un projet de recherche ou à un essai clinique ou encore à suivre un traitement spécifique avec une entière compréhension du but, des résultats attendus, des risques et des avantages ainsi que d’autres traitements disponibles.</li></ul>

 

 

Research and clinical trials387.000000000000Research and clinical trialsResearch and clinical trialsREnglishPregnancyAdult (19+)BodyReproductive systemNAPrenatal Adult (19+)NA2009-09-11T04:00:00ZNicolette Caccia, MEd, MD, FRCSCRory Windrim, MB, MSc, FRCSC8.0000000000000059.00000000000001130.00000000000Flat ContentHealth A-Z<p>Learn about the importance of clinical research. The benefits and complications of phase I, phase II, and phase III trials are discussed.</p><p>A clinical trial is a research study or scientific experiment that examines the use of drugs or other interventions in treatment. It asks a specific question to try and find better ways of preventing, diagnosing, and treating certain conditions in pregnancy, childbirth, or infancy.</p><h2>Key points</h2> <ul><li>There are three phases to clinical trials with the most experimental stage being Phase I.</li> <li>Informed consent is when a person agrees to participate in a research or clinical trial or undergo a specific treatment with a full understanding of the purpose, results expected, risks and benefits and other treatments available. </li></ul> <p>There are three different phases of clinical trials. The most "experimental" stage is Phase I. By the time a treatment reaches a phase III clinical trial, it has been studied well. When a phase III trial is conducted under an organizing group of experts, it may also be called a protocol. </p><h2>The importance of research</h2><p>Research is the only way of improving the success of treatments. Each time a trial shows an improvement with a new type of treatment, this new treatment can be used with more pregnant women or babies. </p><h2>Phase I trials</h2><p>In a Phase I clinical trial, a new drug is tested to see if it is safe to use in humans. This is because it has been tested in laboratory and animal studies, and shown some promise. The goal of a Phase I trial is not to cure the disease or condition, although researchers hope that the drug will be effective. </p><p>Phase I clinical trials usually involve normal, healthy volunteers. A small dose is given to 30 or fewer subjects. The dose is slowly increased during the trial until harmful side effects appear. This is called the maximum tolerated dose. The previous lower dose is then accepted to be a safe dose. This safe dose is used if the drug moves on for further study in Phase II clinical trials. </p><h3>Benefits of phase I trials</h3><p>A Phase I study can help doctors learn how new drugs are used in the body, and to determine the correct dose and dose interval.</p><h3>Potential complications</h3><p>Because the drug is new, the side effects may not be known. Side effects may be serious, and cause pain or discomfort.</p><h2>Phase II trials</h2><p>In Phase II, a drug is tested to see what effect it has on a specific condition. The trial also studies which types of conditions can be treated with the drug. The safe dose that was established in Phase I is tested on 30 to 100 participants. </p><h3>Participating in a phase II trial</h3><p>Phase II trials are offered to people whose condition has not been controlled by other treatments. It also depends on type of condition, the overall health of the patient, and the amount of therapy already received. A limited number of treatment centres offer Phase II trials. </p><h3>Potential benefits of phase II trials</h3><p>The drug may help some participants. The results may help others in the future.</p><h3>Potential complications</h3><p>There may be unexpected and serious side effects. The side effects may cause pain and discomfort.</p><h2>Phase III trials</h2><p>By the time a drug or therapy reaches a Phase III clinical trial, it has gone through Phase I and II trials and appears to work. The drug or intervention is now compared to the treatment current standard treatment or intevention. The goal is to find out which intervention is better. This might be measured by survival rates, side effects, or other outcomes. Participants are randomly assigned to receive one of the two interventions. The trial can involve 100 to 1000 people. </p><h3>Participating in a phase III trial</h3><p>Phase III trials are offered at certain treatment centres to patients entering care. The exact eligibility depends on the goals of the particular study. </p><h3>Potential benefits of phase III trials</h3><p>There is a good chance the drug will help participants. If the drug or intervention proves to be effective in Phase III trials, it may receive government approval to be used for this specific illness. As a result, the drug will eventually be widely available to help or cure many people. </p><h3>Potential complications</h3><p>There may be side effects, but these are known from Phase I and II. A strategy may be in place to help reduce the side effects.</p><h2>Questions to ask about a clinical trial</h2><ul><li>What is the purpose of the clinical trial? </li><li>What is the phase of the clinical trial? </li><li>What is involved in the treatment plan? </li><li>What are the benefits of participating? </li><li>What are the risks of participating? </li><li>Is there any information about how other patients have responded to the same treatment? </li><li>What are the side effects, both in the short- and long-term? How will the side effects be prevented or managed? </li><li>Are any extra diagnostic tests required? </li><li>What effect might this have on other family members? </li></ul><h2>What does informed consent to take part in research or a clinical trial involve?</h2><p>You may be asked to decide whether or not to take part in a research study or a clinical trial. The person asking you to make this decision must make certain you have a full understanding of the purpose of study, the results expected, how the study works, any risks or benefits, and in the case of a clinical trial, the other treatments available. You may ask questions about the study and receive information about the results when the study is finished. </p><p>After explaining this, you will be asked to make a decision about taking part in the study. To give consent to take part, you will sign a consent form describing the research and the risks and benefits. </p><p>If you decide not to take part in a research study or clinical trial, you and your baby will continue to receive the same quality of care from the health-care team and the hospital. If you do decide to take part in the study or trial, signing a consent form is not a contract. You can change your mind, withdraw your consent, and leave the research study or clinical trial at any time. If you decide to withdraw your consent, you and your baby will continue to receive the same quality of care from the health-care team and the hospital. </p><h2>How are new drugs developed?</h2><p>Drug development usually takes a lot of time and research. It begins in the laboratory where a drug has shown to have some effect on a disease or condition in animals, for example. At this stage, it is called pre-clinical research. </p><p>After a drug has shown promise, it will be tested in a clinical trial with humans. Clinical trials move through various phases.</p><p>After each clinical trial, the researchers will write about their findings. They will describe the procedure, the participants, treatment results, side effects, and their understanding of the results. The researchers will send their report to a scientific journal. Other experts who are not connected to the study will read and analyze this report. This is called peer review. If these experts agree that the trial was of high quality, the report will be published. </p><p>After reading the report, other researchers in different cities and countries should be able to repeat similar trials to see if they get the same results. Larger and larger numbers of patients will participate. </p><p>After a number of trials that show its effectiveness, a drug or intervention is approved by a national regulatory body, such as Health Canada , the U.S. Food and Drug Administration, or the Medicines Control Agency in the United Kingdom . Usually, it is first approved for a very particular condition and situation. Later trials help pave the way for the drug to be approved for use with different conditions or age groups.</p><p>This long process shows why the discovery of "miracle cures" in science is so rare. Scientific discovery moves in small steps. Each of these steps involves a clinical trial that takes a great deal of time, effort, collaboration, and thought by many different researchers. </p><p>This scientific process is not always perfect – for example, some journals have higher standards than others – but it is the best way to make sure that a new treatment is safe and effective. </p>Research and clinical trials

Thank you to our sponsors

AboutKidsHealth is proud to partner with the following sponsors as they support our mission to improve the health and wellbeing of children in Canada and around the world by making accessible health care information available via the internet.